Učitavanje...

Steady-State Disposition of the Nonpeptidic Protease Inhibitor Tipranavir when Coadministered with Ritonavir

The pharmacokinetic and metabolite profiles of the antiretroviral agent tipranavir (TPV), administered with ritonavir (RTV), in nine healthy male volunteers were characterized. Subjects received 500-mg TPV capsules with 200-mg RTV capsules twice daily for 6 days. They then received a single oral dos...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Chen, Linzhi, Sabo, John P., Philip, Elsy, Mao, Yanping, Norris, Stephen H., MacGregor, Thomas R., Wruck, Jan M., Garfinkel, Sandra, Castles, Mark, Brinkman, Amy, Valdez, Hernan
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 2007
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1913264/
https://ncbi.nlm.nih.gov/pubmed/17485497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01115-06
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!